InvestmentJun 9, 2026, 05:21 PM
Enveric Biosciences to Offer Additional $2.425M in Common Stock
AI Summary
Enveric Biosciences, Inc. filed a prospectus supplement on June 9, 2026, to offer an additional $2,425,000 of its common stock. This offering is part of an existing At The Market Offering Agreement with H.C. Wainwright & Co., LLC, originally dated April 9, 2025. The company has previously sold $4,483,711.04 through this agreement.
Key Highlights
- Enveric Biosciences filed a prospectus supplement to offer an additional $2,425,000 of common stock.
- The shares are issuable under an At The Market Offering Agreement dated April 9, 2025.
- The company has already sold an aggregate of $4,483,711.04 through the Sales Agent under the ATM Agreement.
- H.C. Wainwright & Co., LLC is the Sales Agent for the offering.
Price Impact
More from ENVB